# ALX Oncology Holdings Inc: Form 8-K, filed Mar 5, 2025

- Company: [ALX Oncology Holdings Inc](/companies/alxo.md) (CIK 1810182)
- Form: 8-K
- Filed: 2025-03-05
- Accepted by EDGAR: Mar 5, 2025, 21:01 ET
- Period: 2025-02-28
- Accession: 0000950170-25-033504
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1810182/000095017025033504/alxo-20250228.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1810182/000095017025033504/

## Items reported

- Item 2.05: Exit or disposal costs
- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1810182/000095017025033504/alxo-20250228.htm

Filed Mar 5, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-033504. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.